EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Cytotoxic Organometallic Iridium(III) Complexes

Irena Kostova iD

Molecules · 2025

DOI: 10.3390/molecules30040801 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecules, 2025. Verfasst von Irena Kostova. Beteiligte Einrichtung: Department of Chemistry, Faculty of Pharmacy, Medical University-Sofia, 1000 Sofia, Bulgaria. Hauptthemen laut MEDLINE: Iridium, Antineoplastic Agents, Coordination Complexes, Organometallic Compounds. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Iridium complexes attract a lot of attention as highly promising antitumor agents due to their various structures, which offer the modification of their physicochemical and biological effects. Compared to conventional platinum-based drugs, iridium complexes are commonly thought to be more active in tumors, resistant to platinum agents and more stable in air and moisture conditions. Chloridoiridium complexes offer a range of advantages facilitating their rational design, reactivity and photochemical activity, leading to different cytotoxic profiles, diverse mechanisms of action and specific intracellular organelles as targets. They are also known as good light-mediated chemotherapeutics, serving as bioimaging and biosensing agents. The potential biological and photophysical properties of chloridoiridium(III) complexes can be readily controlled by suitable ligand modifications and substitution patterns, providing a wide range of versatile structures. Over the years, numerous different structural types of chloridoiridium complexes have been developed and studied for their antineoplastic activity. In this review, the recent advances in the cytotoxicity studies of chloridoiridium(III) compounds have been summarized. The studied complexes have been categorized in this review according to the number of coordinated ligands, the type of donor atoms, nuclearity of the complexes, etc., allowing for a thorough discussion of the structure–activity relationship.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IridiumAntineoplastic AgentsCoordination ComplexesOrganometallic CompoundsHumansStructure-Activity RelationshipAnimalsNeoplasmsMolecular Structure

Stichwörter der Autor:innen

anticancerchloridoiridium(III)complexescytotoxicreview

Substanzen

IridiumAntineoplastic AgentsCoordination ComplexesOrganometallic Compounds

Autor:innen und Institutionen

  • Department of Chemistry, Faculty of Pharmacy, Medical University-Sofia, 1000 Sofia, Bulgaria.

ORCID-Profile: Irena Kostova

Zitieren

APA

Kostova, I. (2025). Cytotoxic Organometallic Iridium(III) Complexes. Molecules. https://doi.org/10.3390/molecules30040801

Vancouver

Kostova I. Cytotoxic Organometallic Iridium(III) Complexes. Molecules. 2025. doi:10.3390/molecules30040801

BibTeX
@article{Kostova2025,
  author = {Kostova, Irena},
  title = {Cytotoxic Organometallic Iridium(III) Complexes},
  journal = {Molecules},
  year = {2025},
  doi = {10.3390/molecules30040801}
}
Kostenlos starten →